Prevalence of systemic lupus erythematosus in Colombia: data from the national health registry 2012–2016

Introduction Registries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of Health has adopted a registry (SISPRO) to gather comprehensive information coming from the Colombian health system, which provides...

Full description

Saved in:
Bibliographic Details
Published inLupus Vol. 28; no. 10; pp. 1273 - 1278
Main Authors Fernández-Ávila, D G, Bernal-Macías, S, Rincón-Riaño, D N, Gutiérrez Dávila, J M, Rosselli, D
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.09.2019
Sage Publications Ltd
Subjects
Online AccessGet full text
ISSN0961-2033
1477-0962
1477-0962
DOI10.1177/0961203319864168

Cover

Abstract Introduction Registries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of Health has adopted a registry (SISPRO) to gather comprehensive information coming from the Colombian health system, which provides close to universal coverage (around 95%). The information collected from SISPRO is available for scientific analysis. Objectives We used data collected by SISPRO to estimate prevalence and specific characteristics of patients with SLE registered from January 2012 to December 2016. Methods This is a descriptive epidemiological study using the International Statistical Classification of Diseases and Related Health Problems as search terms related to SLE, based on SISPRO data. Criteria for diagnosis are not explicitly addressed in each individual case. Results National records report 41,804 patients with a diagnosis of SLE for an estimated prevalence of 91.9/100,000 subjects (based on a total population of 47,663,162), being more frequent in women (89% cases). When adjusted, female and male prevalences were 204.3 and 20.2 per 100,000 (ratio 10.1) with a 7.9:1 female:male ratio, and were highest in the 45–49-year age group. Conclusions This is the first study that describes demographic characteristics of SLE in Colombia, with useful information for decision makers. It also suggests a similar prevalence to other countries.
AbstractList Registries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of Health has adopted a registry (SISPRO) to gather comprehensive information coming from the Colombian health system, which provides close to universal coverage (around 95%). The information collected from SISPRO is available for scientific analysis. We used data collected by SISPRO to estimate prevalence and specific characteristics of patients with SLE registered from January 2012 to December 2016. This is a descriptive epidemiological study using the International Statistical Classification of Diseases and Related Health Problems as search terms related to SLE, based on SISPRO data. Criteria for diagnosis are not explicitly addressed in each individual case. National records report 41,804 patients with a diagnosis of SLE for an estimated prevalence of 91.9/100,000 subjects (based on a total population of 47,663,162), being more frequent in women (89% cases). When adjusted, female and male prevalences were 204.3 and 20.2 per 100,000 (ratio 10.1) with a 7.9:1 female:male ratio, and were highest in the 45-49-year age group. This is the first study that describes demographic characteristics of SLE in Colombia, with useful information for decision makers. It also suggests a similar prevalence to other countries.
Introduction Registries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of Health has adopted a registry (SISPRO) to gather comprehensive information coming from the Colombian health system, which provides close to universal coverage (around 95%). The information collected from SISPRO is available for scientific analysis. Objectives We used data collected by SISPRO to estimate prevalence and specific characteristics of patients with SLE registered from January 2012 to December 2016. Methods This is a descriptive epidemiological study using the International Statistical Classification of Diseases and Related Health Problems as search terms related to SLE, based on SISPRO data. Criteria for diagnosis are not explicitly addressed in each individual case. Results National records report 41,804 patients with a diagnosis of SLE for an estimated prevalence of 91.9/100,000 subjects (based on a total population of 47,663,162), being more frequent in women (89% cases). When adjusted, female and male prevalences were 204.3 and 20.2 per 100,000 (ratio 10.1) with a 7.9:1 female:male ratio, and were highest in the 45–49-year age group. Conclusions This is the first study that describes demographic characteristics of SLE in Colombia, with useful information for decision makers. It also suggests a similar prevalence to other countries.
Registries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of Health has adopted a registry (SISPRO) to gather comprehensive information coming from the Colombian health system, which provides close to universal coverage (around 95%). The information collected from SISPRO is available for scientific analysis.INTRODUCTIONRegistries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of Health has adopted a registry (SISPRO) to gather comprehensive information coming from the Colombian health system, which provides close to universal coverage (around 95%). The information collected from SISPRO is available for scientific analysis.We used data collected by SISPRO to estimate prevalence and specific characteristics of patients with SLE registered from January 2012 to December 2016.OBJECTIVESWe used data collected by SISPRO to estimate prevalence and specific characteristics of patients with SLE registered from January 2012 to December 2016.This is a descriptive epidemiological study using the International Statistical Classification of Diseases and Related Health Problems as search terms related to SLE, based on SISPRO data. Criteria for diagnosis are not explicitly addressed in each individual case.METHODSThis is a descriptive epidemiological study using the International Statistical Classification of Diseases and Related Health Problems as search terms related to SLE, based on SISPRO data. Criteria for diagnosis are not explicitly addressed in each individual case.National records report 41,804 patients with a diagnosis of SLE for an estimated prevalence of 91.9/100,000 subjects (based on a total population of 47,663,162), being more frequent in women (89% cases). When adjusted, female and male prevalences were 204.3 and 20.2 per 100,000 (ratio 10.1) with a 7.9:1 female:male ratio, and were highest in the 45-49-year age group.RESULTSNational records report 41,804 patients with a diagnosis of SLE for an estimated prevalence of 91.9/100,000 subjects (based on a total population of 47,663,162), being more frequent in women (89% cases). When adjusted, female and male prevalences were 204.3 and 20.2 per 100,000 (ratio 10.1) with a 7.9:1 female:male ratio, and were highest in the 45-49-year age group.This is the first study that describes demographic characteristics of SLE in Colombia, with useful information for decision makers. It also suggests a similar prevalence to other countries.CONCLUSIONSThis is the first study that describes demographic characteristics of SLE in Colombia, with useful information for decision makers. It also suggests a similar prevalence to other countries.
IntroductionRegistries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of Health has adopted a registry (SISPRO) to gather comprehensive information coming from the Colombian health system, which provides close to universal coverage (around 95%). The information collected from SISPRO is available for scientific analysis.ObjectivesWe used data collected by SISPRO to estimate prevalence and specific characteristics of patients with SLE registered from January 2012 to December 2016.MethodsThis is a descriptive epidemiological study using the International Statistical Classification of Diseases and Related Health Problems as search terms related to SLE, based on SISPRO data. Criteria for diagnosis are not explicitly addressed in each individual case.ResultsNational records report 41,804 patients with a diagnosis of SLE for an estimated prevalence of 91.9/100,000 subjects (based on a total population of 47,663,162), being more frequent in women (89% cases). When adjusted, female and male prevalences were 204.3 and 20.2 per 100,000 (ratio 10.1) with a 7.9:1 female:male ratio, and were highest in the 45–49-year age group.ConclusionsThis is the first study that describes demographic characteristics of SLE in Colombia, with useful information for decision makers. It also suggests a similar prevalence to other countries.
Author Rincón-Riaño, D N
Fernández-Ávila, D G
Gutiérrez Dávila, J M
Bernal-Macías, S
Rosselli, D
Author_xml – sequence: 1
  givenname: D G
  surname: Fernández-Ávila
  fullname: Fernández-Ávila, D G
– sequence: 2
  givenname: S
  orcidid: 0000-0002-7010-8338
  surname: Bernal-Macías
  fullname: Bernal-Macías, S
– sequence: 3
  givenname: D N
  surname: Rincón-Riaño
  fullname: Rincón-Riaño, D N
– sequence: 4
  givenname: J M
  surname: Gutiérrez Dávila
  fullname: Gutiérrez Dávila, J M
– sequence: 5
  givenname: D
  surname: Rosselli
  fullname: Rosselli, D
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31354025$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1q3DAQx0VIaHbT3HMqgl56cTOSbNnurSz5KASSQ3o2Wnmc1SJbW0kO7C3vkDfsk0TOJi0stJcZZub3H-ZjTg4HNyAhZwy-MlaW51BLxkEIVlcyZ7I6IDOWl2WW8vyQzKZyNtWPyTyENQAkUn4gx4KJIgdezMj6zuOjsjhopK6jYRsi9kZTO27GQNFv4wp7FV1IkRnowlnXL436RlsVFe2862ki6KCicYOydIXKxhX1-GBC9FvKgfHfT8_JyY_kqFM24OmbPyE_Ly_uF9fZze3Vj8X3m0wLWcRM60IVAG0Fy2TT8F2hUIq8KrFseaGlWLIub0UNrE57MymEqKAQIJSQDHJxQr7s-m68-zViiE1vgkZr1YBuDA3nMmlynlcJ_byHrt3o0x4TVYGoa8anhp_eqHHZY9tsvOmV3zbvV0wA7ADtXQgeuz8Ig2Z6VLP_qCSRexJt4usRo1fG_k-Y7YRBPeDfcf_JvwBpLp__
CitedBy_id crossref_primary_10_1016_j_rcreu_2021_06_008
crossref_primary_10_1371_journal_pone_0273324
crossref_primary_10_1016_j_acci_2023_07_003
crossref_primary_10_1016_j_clicom_2023_10_002
crossref_primary_10_1016_j_msard_2023_104915
crossref_primary_10_1080_24725625_2021_1909213
crossref_primary_10_1016_j_reuma_2024_09_005
crossref_primary_10_1016_j_rcreu_2024_06_002
crossref_primary_10_7759_cureus_42053
crossref_primary_10_1016_j_vhri_2021_04_005
crossref_primary_10_1371_journal_pone_0285889
crossref_primary_10_1155_crin_5285961
crossref_primary_10_1016_j_rcreu_2021_10_004
crossref_primary_10_1038_s41584_021_00668_1
crossref_primary_10_1080_14656566_2025_2464913
crossref_primary_10_1016_j_rcreu_2021_05_008
crossref_primary_10_1038_s41598_024_72564_z
crossref_primary_10_1007_s11657_024_01412_4
crossref_primary_10_1080_13696998_2024_2316536
crossref_primary_10_1177_0961203319878498
crossref_primary_10_1016_j_rcreu_2021_03_003
crossref_primary_10_1177_09612033231184315
crossref_primary_10_1016_j_reumae_2024_09_006
crossref_primary_10_1016_j_rcreue_2021_05_001
crossref_primary_10_1007_s00296_022_05183_4
crossref_primary_10_1016_j_jtauto_2021_100133
crossref_primary_10_1016_j_reumae_2024_11_003
crossref_primary_10_1016_j_rcreue_2021_07_004
crossref_primary_10_1016_j_rcreue_2021_10_010
crossref_primary_10_4081_reumatismo_2023_1568
crossref_primary_10_1016_j_rcreu_2021_05_018
crossref_primary_10_1016_j_rcreu_2021_02_009
crossref_primary_10_1016_j_rcreue_2023_07_003
crossref_primary_10_1097_MD_0000000000019797
crossref_primary_10_1016_j_rcreu_2024_02_006
crossref_primary_10_1055_s_0041_1733844
crossref_primary_10_3390_ijerph17041315
crossref_primary_10_1016_j_reuma_2024_06_006
crossref_primary_10_1016_j_rcreu_2021_07_001
crossref_primary_10_1016_j_rcreue_2021_02_005
Cites_doi 10.1177/0961203310374305
10.1053/berh.2002.0259
10.1016/j.autrev.2013.12.002
10.1016/S1568-9972(03)00006-5
10.1016/j.rdc.2009.12.005
10.1097/BOR.0000000000000198
10.1093/rheumatology/32.2.110
10.1080/1744666X.2017.1327352
10.1016/0002-9343(91)90151-M
10.1002/art.38238
10.2165/11598550-000000000-00000
10.1177/0961203313512881
10.1177/0961203311412096
10.1002/art.1780380914
10.1002/acr.20683
10.1002/art.1780380415
10.1136/lupus-2014-000021
10.1177/0961203309106831
10.1093/rheumatology/37.5.491
10.1159/000381424
10.1186/ar2368
10.1016/S0140-6736(07)60279-7
10.1136/annrheumdis-2018-213512
ContentType Journal Article
Copyright The Author(s) 2019
Copyright_xml – notice: The Author(s) 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
7X8
DOI 10.1177/0961203319864168
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1477-0962
EndPage 1278
ExternalDocumentID 31354025
10_1177_0961203319864168
10.1177_0961203319864168
Genre Journal Article
GeographicLocations Colombia
GeographicLocations_xml – name: Colombia
GroupedDBID ---
-TM
.2E
.2F
.2G
.2J
.2N
.GJ
01A
0R~
18M
1~K
29L
31R
31S
31U
31X
31Y
31Z
36B
39C
4.4
53G
54M
5GY
5VS
7X7
88E
8FI
8FJ
8R4
8R5
AABMB
AABOD
AACKU
AACMV
AACTG
AADUE
AAEWN
AAGGD
AAGLT
AAGMC
AAJIQ
AAJOX
AAJPV
AAKGS
AANSI
AAPEO
AAQDB
AAQXH
AAQXI
AARDL
AARIX
AATAA
AATBZ
AAUAS
AAXOT
AAYTG
AAZBJ
ABAFQ
ABAWP
ABCCA
ABCJG
ABDBF
ABDWY
ABEIX
ABFWQ
ABHKI
ABHQH
ABIDT
ABJIS
ABJZC
ABKRH
ABLUO
ABOCM
ABPGX
ABPNF
ABQKF
ABQXT
ABRHV
ABUJY
ABUWG
ABVFX
ABVVC
ABYTW
ACARO
ACDSZ
ACDXX
ACFEJ
ACFMA
ACFYK
ACGBL
ACGFO
ACGFS
ACGZU
ACJER
ACJTF
ACLFY
ACLHI
ACLZU
ACOFE
ACOXC
ACPRK
ACROE
ACRPL
ACSIQ
ACUAV
ACUHS
ACUIR
ACXKE
ACXMB
ADBBV
ADDLC
ADEBD
ADEIA
ADMPF
ADNBR
ADNMO
ADNON
ADRRZ
ADSTG
ADTBJ
ADUCT
ADUKL
ADVBO
ADYCS
ADZZY
AECGH
AECVZ
AEDTQ
AEGXH
AEKYL
AENEX
AEPTA
AEQLS
AERKM
AESZF
AEUHG
AEWDL
AEWHI
AEXFG
AEXNY
AFEET
AFKBI
AFKRA
AFKRG
AFMOU
AFOSN
AFQAA
AFUIA
AFWMB
AGHKR
AGKLV
AGNHF
AGPXR
AGQPQ
AGWFA
AGWNL
AHDMH
AHMBA
AIAGR
AIGRN
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
AJXAJ
ALIPV
ALKWR
ALMA_UNASSIGNED_HOLDINGS
AMCVQ
ANDLU
ARTOV
ASPBG
AUTPY
AUVAJ
AVWKF
AYAKG
AZFZN
AZQEC
B3H
B8M
B8O
B8R
B8Z
B93
B94
BBRGL
BDDNI
BENPR
BKIIM
BKNYI
BKSCU
BPACV
BPHCQ
BSEHC
BVXVI
BWJAD
BYIEH
C45
CBRKF
CCPQU
CDWPY
CFDXU
CORYS
CQQTX
CS3
CUTAK
DB0
DC-
DC0
DD-
DD0
DE-
DF0
DO-
DOPDO
DU5
DV7
DV9
D~Y
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
FEDTE
FHBDP
FYUFA
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HMCUK
HVGLF
HZ~
J8X
K.F
K.J
K9-
M0R
M1P
N9A
O9-
OVD
P.B
P2P
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
Q1R
Q2X
Q7K
Q7L
Q7R
Q7U
Q7X
Q82
Q83
ROL
S01
SASJQ
SAUOL
SCNPE
SDB
SFB
SFC
SFK
SFN
SFT
SGA
SGO
SGP
SGR
SGV
SGX
SGZ
SHG
SNB
SPJ
SPQ
SPV
SQCSI
STM
SV3
TEORI
TUS
UKHRP
ZONMY
ZPPRI
ZRKOI
ZSSAH
AAYXX
AJGYC
CITATION
ALTZF
CGR
CUY
CVF
ECM
EIF
M4V
NPM
7T5
AAPII
AJVBE
H94
K9.
7X8
AJHME
ID FETCH-LOGICAL-c365t-cc5a500d80b00d033f5ae63487e7d25c63b1f4d3901919816333805303a361043
ISSN 0961-2033
1477-0962
IngestDate Fri Sep 05 08:49:16 EDT 2025
Fri Jul 25 02:58:10 EDT 2025
Thu Apr 03 07:04:09 EDT 2025
Thu Apr 24 22:50:22 EDT 2025
Tue Jul 01 05:22:55 EDT 2025
Tue Jun 17 22:45:31 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Colombia
systemic lupus erythematosus
registries
Latin America
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c365t-cc5a500d80b00d033f5ae63487e7d25c63b1f4d3901919816333805303a361043
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7010-8338
PMID 31354025
PQID 2280399124
PQPubID 32637
PageCount 6
ParticipantIDs proquest_miscellaneous_2266334248
proquest_journals_2280399124
pubmed_primary_31354025
crossref_primary_10_1177_0961203319864168
crossref_citationtrail_10_1177_0961203319864168
sage_journals_10_1177_0961203319864168
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20190900
2019-09-00
2019-Sep
20190901
PublicationDateYYYYMMDD 2019-09-01
PublicationDate_xml – month: 9
  year: 2019
  text: 20190900
PublicationDecade 2010
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: England
– name: London
PublicationTitle Lupus
PublicationTitleAlternate Lupus
PublicationYear 2019
Publisher SAGE Publications
Sage Publications Ltd
Publisher_xml – name: SAGE Publications
– name: Sage Publications Ltd
References Farooqi, Gibson 1998; 37
Pons-Estel, Bonfa, Soriano 2018; 77
Osio-Salido, Manapat-Reyes 2010; 19
Calixto, Anaya 2014; 13
Lim, Drenkard 2015; 27
Pons-Estel, Ugarte-Gil, Alarcón 2017; 13
D’Cruz, Khamashta, Hughes 2007; 369
Pineles, Valente, Warren, Peterson, Lehman, Moorthy 2011; 20
Vasudevan, Krishnamurthy 2010; 36
Méndez-Ayala, Nariño, Rosselli 2015; 44
Jakes, Bae, Louthrenoo, Mok, Navarra, Kwon 2012; 64
Petri, Perez-Gutthann, Longenecker, Hochberg 1991; 91
Somers, Marder, Cagnoli 2014; 66
Nasonov, Soloviev, Davidson 2014; 23
Scolnik, Marin, Valeiras 2014; 1
Ståhl-Hallengren, Jönsen, Nived, Sturfelt 2000; 27
McCarty, Manzi, Medsger TA, Ramsey-Goldman, Laporte, Kwoh 1995; 38
Petri 2002; 16
Zeng, Chen, Darmawan 2008; 10
Arnaud, Mathian, Boddaert, Amoura 2012; 29
Cooper, Stroehla 2003; 2
Cervera, Khamashta, Hughes 2009; 18
bibr5-0961203319864168
bibr22-0961203319864168
bibr1-0961203319864168
bibr18-0961203319864168
bibr14-0961203319864168
bibr9-0961203319864168
bibr27-0961203319864168
bibr10-0961203319864168
bibr15-0961203319864168
bibr23-0961203319864168
bibr2-0961203319864168
Ståhl-Hallengren C (bibr20-0961203319864168) 2000; 27
bibr19-0961203319864168
bibr24-0961203319864168
bibr6-0961203319864168
bibr11-0961203319864168
bibr28-0961203319864168
bibr16-0961203319864168
bibr25-0961203319864168
bibr3-0961203319864168
bibr12-0961203319864168
bibr7-0961203319864168
bibr4-0961203319864168
bibr21-0961203319864168
bibr17-0961203319864168
bibr26-0961203319864168
bibr8-0961203319864168
bibr13-0961203319864168
31581893 - Lupus. 2019 Nov;28(13):1610-1611
References_xml – volume: 64
  start-page: 159
  year: 2012
  end-page: 168
  article-title: Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality
  publication-title: Arthritis Care Res (Hoboken)
– volume: 1
  start-page: e000021
  year: 2014
  end-page: e000021
  article-title: Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study
  publication-title: Lupus Sci Med
– volume: 10
  start-page: R17
  year: 2008
  end-page: R17
  article-title: Rheumatic diseases in China
  publication-title: Arthritis Res Ther
– volume: 38
  start-page: 1260
  year: 1995
  end-page: 1270
  article-title: Incidence of systemic lupus erythematosus. Race and gender differences
  publication-title: Arthritis Rheum
– volume: 37
  start-page: 491
  year: 1998
  end-page: 495
  article-title: Prevalence of the major rheumatic disorders in the adult population of north Pakistan
  publication-title: Br J Rheumatol
– volume: 27
  start-page: 685
  year: 2000
  end-page: 691
  article-title: Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis
  publication-title: J Rheumatol
– volume: 19
  start-page: 1365
  year: 2010
  end-page: 1373
  article-title: Epidemiology of systemic lupus erythematosus in Asia
  publication-title: Lupus
– volume: 13
  start-page: 799
  year: 2017
  end-page: 814
  article-title: Epidemiology of systemic lupus erythematosus
  publication-title: Expert Rev Clin Immunol
– volume: 91
  start-page: 345
  year: 1991
  end-page: 353
  article-title: Morbidity of systemic lupus erythematosus: role of race and socioeconomic status
  publication-title: Am J Med
– volume: 23
  start-page: 213
  year: 2014
  end-page: 219
  article-title: The prevalence and incidence of systemic lupus erythematosus (SLE) in selected cities from three Commonwealth of Independent States countries (the Russian Federation, Ukraine and Kazakhstan)
  publication-title: Lupus
– volume: 29
  start-page: 181
  year: 2012
  end-page: 189
  article-title: Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment
  publication-title: Drugs Aging
– volume: 13
  start-page: 641
  year: 2014
  end-page: 654
  article-title: Socioeconomic status. The relationship with health and autoimmune diseases
  publication-title: Autoimmun Rev
– volume: 20
  start-page: 1187
  year: 2011
  end-page: 1192
  article-title: Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus
  publication-title: Lupus
– volume: 77
  start-page: 1549
  year: 2018
  end-page: 1557
  article-title: First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR)
  publication-title: Ann Rheum Dis
– volume: 16
  start-page: 847
  year: 2002
  end-page: 858
  article-title: Epidemiology of systemic lupus erythematosus
  publication-title: Best Pract Res Clin Rheumatol
– volume: 18
  start-page: 869
  year: 2009
  end-page: 874
  article-title: The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe
  publication-title: Lupus
– volume: 369
  start-page: 587
  year: 2007
  end-page: 596
  article-title: Systemic lupus erythematosus
  publication-title: Lancet
– volume: 36
  start-page: 1
  year: 2010
  end-page: 13
  article-title: Changing worldwide epidemiology of systemic lupus erythematosus
  publication-title: Rheum Dis Clin North Am
– volume: 27
  start-page: 427
  year: 2015
  end-page: 432
  article-title: Epidemiology of lupus: an update
  publication-title: Curr Opin Rheumatol
– volume: 2
  start-page: 119
  year: 2003
  end-page: 125
  article-title: The epidemiology of autoimmune diseases
  publication-title: Autoimmun Rev
– volume: 44
  start-page: 144
  year: 2015
  end-page: 148
  article-title: Burden of epilepsy in Colombia
  publication-title: Neuroepidemiology
– volume: 66
  start-page: 369
  year: 2014
  end-page: 378
  article-title: Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program
  publication-title: Arthritis Rheumatol
– ident: bibr15-0961203319864168
  doi: 10.1177/0961203310374305
– ident: bibr3-0961203319864168
– ident: bibr14-0961203319864168
  doi: 10.1053/berh.2002.0259
– ident: bibr12-0961203319864168
  doi: 10.1016/j.autrev.2013.12.002
– ident: bibr2-0961203319864168
  doi: 10.1016/S1568-9972(03)00006-5
– ident: bibr5-0961203319864168
– ident: bibr1-0961203319864168
  doi: 10.1016/j.rdc.2009.12.005
– ident: bibr22-0961203319864168
  doi: 10.1097/BOR.0000000000000198
– ident: bibr27-0961203319864168
  doi: 10.1093/rheumatology/32.2.110
– ident: bibr10-0961203319864168
– ident: bibr9-0961203319864168
  doi: 10.1080/1744666X.2017.1327352
– ident: bibr13-0961203319864168
  doi: 10.1016/0002-9343(91)90151-M
– ident: bibr16-0961203319864168
  doi: 10.1002/art.38238
– ident: bibr24-0961203319864168
  doi: 10.2165/11598550-000000000-00000
– ident: bibr21-0961203319864168
  doi: 10.1177/0961203313512881
– ident: bibr28-0961203319864168
  doi: 10.1177/0961203311412096
– ident: bibr23-0961203319864168
  doi: 10.1002/art.1780380914
– volume: 27
  start-page: 685
  year: 2000
  ident: bibr20-0961203319864168
  publication-title: J Rheumatol
– ident: bibr17-0961203319864168
  doi: 10.1002/acr.20683
– ident: bibr26-0961203319864168
  doi: 10.1002/art.1780380415
– ident: bibr8-0961203319864168
  doi: 10.1136/lupus-2014-000021
– ident: bibr25-0961203319864168
  doi: 10.1177/0961203309106831
– ident: bibr18-0961203319864168
  doi: 10.1093/rheumatology/37.5.491
– ident: bibr6-0961203319864168
  doi: 10.1159/000381424
– ident: bibr19-0961203319864168
  doi: 10.1186/ar2368
– ident: bibr11-0961203319864168
  doi: 10.1016/S0140-6736(07)60279-7
– ident: bibr4-0961203319864168
– ident: bibr7-0961203319864168
  doi: 10.1136/annrheumdis-2018-213512
– reference: 31581893 - Lupus. 2019 Nov;28(13):1610-1611
SSID ssj0003196
Score 2.4271345
Snippet Introduction Registries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian...
Registries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of...
IntroductionRegistries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian...
SourceID proquest
pubmed
crossref
sage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1273
SubjectTerms Adolescent
Adult
Age Distribution
Aged
Aged, 80 and over
Child
Child, Preschool
Colombia - epidemiology
Diagnosis
Epidemiology
Female
Humans
Infant
Lupus
Lupus Erythematosus, Systemic - diagnosis
Lupus Erythematosus, Systemic - epidemiology
Male
Middle Aged
Prevalence
Registries
Sex Distribution
Systemic lupus erythematosus
Young Adult
Title Prevalence of systemic lupus erythematosus in Colombia: data from the national health registry 2012–2016
URI https://journals.sagepub.com/doi/full/10.1177/0961203319864168
https://www.ncbi.nlm.nih.gov/pubmed/31354025
https://www.proquest.com/docview/2280399124
https://www.proquest.com/docview/2266334248
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLZKJyFuEP8UBjISQkJRttjOX7lbKWOaGBfTJu2uShxHylSSqW2Q2BXvwEvxHDwJ59iJk5YNMW4iJ3HtJOfr8fH5JeR1nvE8C2TswuKuXD-G1hi6uj7wvjzlCRZdRW-Lz-HBqX94FpwNBj97Xkv1Kt2Rl1fGlfwPVeEa0BWjZG9AWTsoXIA20BeOQGE4_hONMf9SoqOGUOYzSZkL6czri3rpqMU3k5G1WtZLE9w3r76khS7Gg46hXWiJ1QiaqEgHqzVgETgH1m3eukMIOAn7suwnnKavj9ZGd4ZKaRebMftazI05qavgNdE5p92jROreUxNPZiXS46LUNyaidI_hUbHJKjOGNRp9hE9qDPyLhbp0pmbedrLDRsHbqDJY56tldZIhAwKbzBg7ynBkP4qg3zrL5nEfml6PATMeid5iDqfx1QuFNlXjhDgfwyT1zNT3Wc_JvbFWWg9G1qZJ3xjhFtniEUhxQ7K1N5lO9q1UgKxO531sXrEzme9ujrEuIv2x71nzOdRi0Mk9crfZv9A9A8b7ZKDKB-T2UeOh8ZCcd5ikVU5bTFKNSbqGSVqUtMXkO4qIpIhICj1oi0hqEElbRFJE5K_vPxCLj8jp_oeT9wduU8_DlSIMVq6UAdbfyGIPeH0GL5wHiQoFbJlVlPFAhiJluZ-hFm4M3wJ2CkLEsEh4IhEg5fviMRmWVameEhr6KuZpEHk8hy13ko2jzJNY-SHzmPSVGpHd9hPOZJPsHmuuzGfXEW5E3tpfXJhEL3_pu91SZdawg-UM80qBtA_y8oi8sreBWaMFLilVVWMfgIbwuQ9DPDHUtJMJhipYHozIGyRvN_B1T_HsBk_8nNzp_nDbZLha1OoFSNOr9GUD1N8hv7VM
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+systemic+lupus+erythematosus+in+Colombia%3A+data+from+the+national+health+registry+2012%E2%80%932016&rft.jtitle=Lupus&rft.au=Fern%C3%A1ndez-%C3%81vila%2C+D+G&rft.au=Bernal-Mac%C3%ADas%2C+S&rft.au=Rinc%C3%B3n-Ria%C3%B1o%2C+D+N&rft.au=Guti%C3%A9rrez+D%C3%A1vila%2C+J+M&rft.date=2019-09-01&rft.issn=0961-2033&rft.eissn=1477-0962&rft.volume=28&rft.issue=10&rft.spage=1273&rft.epage=1278&rft_id=info:doi/10.1177%2F0961203319864168&rft.externalDBID=n%2Fa&rft.externalDocID=10_1177_0961203319864168
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0961-2033&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0961-2033&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0961-2033&client=summon